Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Jiae | - |
dc.contributor.author | Cho, Chang Hun | - |
dc.contributor.author | Hahn, Hoh-Gyu | - |
dc.contributor.author | Choi, Soo-Young | - |
dc.contributor.author | Cho, Sung-Woo | - |
dc.date.accessioned | 2024-01-20T02:32:27Z | - |
dc.date.available | 2024-01-20T02:32:27Z | - |
dc.date.created | 2021-09-05 | - |
dc.date.issued | 2017-01 | - |
dc.identifier.issn | 0361-9230 | - |
dc.identifier.uri | https://pubs.kist.re.kr/handle/201004/123250 | - |
dc.description.abstract | We previously reported that N-adamantyl-4-methylthiazol-2-amine (KHG26693) suppresses amyloid beta (A beta)-induced neuronal oxidative damage in cortical neurons. Here we investigated the mechanism and antioxidative function of KHG26693 in the hippocampus of A beta-treated mice. KHG26693 significantly attenuated A beta-induced TNF-alpha and IL-1 beta enhancements. KHG26693 decreased A beta-mediated malondialdehyde formation, protein oxidation, and reactive oxygen species by decreasing the iNOS level. KHG26693 suppressed A beta-induced oxidative stress through a mechanism involving glutathione peroxidase, catalase, and GSH attenuation. A beta-induced MMP-2, cPLA2, and pcPLA2 expressions were almost completely attenuated by KHG26693 treatment, suggesting that A beta-induced oxidative stress reduction by KHG26693 is, at least partly, caused by the downregulation of MMP-2 and cPLA2 activation. Compared with A beta treatment, KHG26693 treatment upregulated Nrf2 and HO-1 expressions, suggesting that KHG26693 protects the brain from AP-induced oxidative damage, likely by maintaining redox balance through Nrf2/HO-1 pathway regulation. KHG26693 significantly attenuated A beta-induced oxidative stress in the hippocampus of A beta-treated mice. (C) 2016 Elsevier Inc. All rights reserved. | - |
dc.language | English | - |
dc.publisher | PERGAMON-ELSEVIER SCIENCE LTD | - |
dc.subject | CYTOSOLIC PHOSPHOLIPASE A(2) | - |
dc.subject | ALZHEIMERS-DISEASE | - |
dc.subject | RAT MODEL | - |
dc.subject | DERIVATIVES | - |
dc.subject | EXPRESSION | - |
dc.subject | DAMAGE | - |
dc.subject | BRAIN | - |
dc.subject | TRANSCRIPTION | - |
dc.subject | ACTIVATION | - |
dc.subject | OLIGOMERS | - |
dc.title | Neuroprotective effects of N-adamantyl-4-methylthiazol-2-amine against amyloid beta-induced oxidative stress in mouse hippocampus | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/j.brainresbull.2016.10.010 | - |
dc.description.journalClass | 1 | - |
dc.identifier.bibliographicCitation | BRAIN RESEARCH BULLETIN, v.128, pp.22 - 28 | - |
dc.citation.title | BRAIN RESEARCH BULLETIN | - |
dc.citation.volume | 128 | - |
dc.citation.startPage | 22 | - |
dc.citation.endPage | 28 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.identifier.wosid | 000392354000004 | - |
dc.identifier.scopusid | 2-s2.0-84995814830 | - |
dc.relation.journalWebOfScienceCategory | Neurosciences | - |
dc.relation.journalResearchArea | Neurosciences & Neurology | - |
dc.type.docType | Article | - |
dc.subject.keywordPlus | CYTOSOLIC PHOSPHOLIPASE A(2) | - |
dc.subject.keywordPlus | ALZHEIMERS-DISEASE | - |
dc.subject.keywordPlus | RAT MODEL | - |
dc.subject.keywordPlus | DERIVATIVES | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | DAMAGE | - |
dc.subject.keywordPlus | BRAIN | - |
dc.subject.keywordPlus | TRANSCRIPTION | - |
dc.subject.keywordPlus | ACTIVATION | - |
dc.subject.keywordPlus | OLIGOMERS | - |
dc.subject.keywordAuthor | Amyloid beta | - |
dc.subject.keywordAuthor | Alzheimer&apos | - |
dc.subject.keywordAuthor | s disease | - |
dc.subject.keywordAuthor | Oxidative stress | - |
dc.subject.keywordAuthor | N-Adamantyl-4-methylthiazol-2-amine | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.